High materiality7/10
Amgen price target raised to $420 from $400 at UBS
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises AMGN target to $420 from $400; current price $358.68; upside potential remains to target.
- Target: $420 (from $400)
- Price: $358.68
- Upside to target
Key facts
- 01
Target: $420
- 02
Posted price: $358.68
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.